SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-071207
Filing Date
2022-11-10
Accepted
2022-11-10 16:23:00
Documents
66
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_180lifesci.htm   iXBRL 10-Q 992429
2 CERTIFICATION EXHIBIT f10q0922ex31-1_180lifesci.htm EX-31.1 9676
3 CERTIFICATION EXHIBIT f10q0922ex31-2_180lifesci.htm EX-31.2 9811
4 CERTIFICATION EXHIBIT f10q0922ex32-1_180lifesci.htm EX-32.1 3502
5 CERTIFICATION EXHIBIT f10q0922ex32-2_180lifesci.htm EX-32.2 3506
6 GRAPHIC image_001.jpg GRAPHIC 2287
  Complete submission text file 0001213900-22-071207.txt   5896358

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE atnf-20220930.xsd EX-101.SCH 76781
8 XBRL CALCULATION FILE atnf-20220930_cal.xml EX-101.CAL 36437
9 XBRL DEFINITION FILE atnf-20220930_def.xml EX-101.DEF 294782
10 XBRL LABEL FILE atnf-20220930_lab.xml EX-101.LAB 654754
11 XBRL PRESENTATION FILE atnf-20220930_pre.xml EX-101.PRE 317911
60 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_180lifesci_htm.xml XML 734306
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38105 | Film No.: 221377614
SIC: 2834 Pharmaceutical Preparations